Epsilon M&A Deal Report - Cisbio Bioassays
Transaction Multiples for the Valuation of Private Companies
Private Group led by Argos Soditic / Cisbio Bioassays
No EMAT :
63495
Announced Date :
14/05/2013
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Argos Soditic
Target :
Cisbio Bioassays
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 1986, Cisbio Bioassays, is a life sciences company developing and marketing products used for in-vitro diagnostics and drug discovery . > Develops various assays and reagents for...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 25/03/2014 | Sinclair IS Pharma | AQTIS Medical | Netherlands | * | 63385 |
| 14/01/2014 | Alliance Pharma | Irenat | Germany | * | 63373 |
Source: Epsilon Research / EMAT
